These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PSYCHOTIC REACTIONS DURING THERAPY WITH PARGYLINE. SUTNICK AI; WEISS LB; SCHINDLER PD; SOLOFF LA JAMA; 1964 May; 188():610-1. PubMed ID: 14159527 [No Abstract] [Full Text] [Related]
4. A COMPARATIVE CLINICAL STUDY OF METHYCLOTHIAZIDE AND PARGYLINE IN PATIENTS WITH ESSENTIAL HYPERTENSION. PATEL N; MOCK DC; COLMORE JP; CLARK M Clin Pharmacol Ther; 1963; 4():740-8. PubMed ID: 14085302 [No Abstract] [Full Text] [Related]
5. HYPERTENSIVE REACTION TO PARGYLINE AND CHEESE. BEASLEY EW Lancet; 1964 Sep; 2(7359):586-7. PubMed ID: 14172373 [No Abstract] [Full Text] [Related]
6. PARGYLINE HYDROCHLORIDE AS AN ANTIHYPERTENSIVE AGENT. LEE RE Am Heart J; 1963 Dec; 66():833-4. PubMed ID: 14090325 [No Abstract] [Full Text] [Related]
7. PARGYLINE HYDROCHLORIDE AS AN ANTIHYPERTENSIVE AGENT WITH AND WITHOUT A THIAZIDE. TOROSDAG S; SCHVARTZ N; FLETCHER L; FERTIG H; SCHWARTZ MS; QUAN RB; BRYANT JM Am J Cardiol; 1963 Dec; 12():822-7. PubMed ID: 14088219 [No Abstract] [Full Text] [Related]
8. DANGEROUS POTENTIATION OF MEPERIDINE HYDROCHLORIDE BY PARGYLINE HYDROCHLORIDE. VIGRAN IM JAMA; 1964 Mar; 187():953-4. PubMed ID: 14100156 [No Abstract] [Full Text] [Related]
9. MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS. GOLDBERG LI JAMA; 1964 Nov; 190():456-62. PubMed ID: 14197995 [No Abstract] [Full Text] [Related]
10. EXPERIENCE WITH PARGYLINE HYDROCHLORIDE (NONHYDRAZINE MONOAMINE OXIDASE INHIBITOR) AS AN ANTIHYPERTENSIVE AGENT: PRELIMINARY OBSERVATIONS IN 32 PATIENTS. KAVANAUGH GJ; SHEPS SG; FAIRBAIRN JF; OSMUNDSON PJ; SCHIRGER A Minn Med; 1965 Jun; 48():731-5. PubMed ID: 14287386 [No Abstract] [Full Text] [Related]
11. CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION. MAXWELL MH; ROTH SI; GONICK HC; KLEEMAN CR Am Heart J; 1963 Aug; 66():151-63. PubMed ID: 14051181 [No Abstract] [Full Text] [Related]
12. Hypertension: effectiveness of two drugs. Burke GE Tex Med; 1967 May; 63(5):72-5. PubMed ID: 4860124 [No Abstract] [Full Text] [Related]
13. PARGYLINE HYDROCHLORIDE, A NEW ANTIHYPERTENSIVE AGENT. SUTNICK AI; FEWELL JW; ESBENSHADE JH; SOLOFF LA Clin Pharmacol Ther; 1964; 5():167-73. PubMed ID: 14155158 [No Abstract] [Full Text] [Related]
15. [RECURRING LEFT HEMIPLEGIA SECONDARY TO A MEDICAMENTOUS ORTHOSTATIC HYPOTENSION CAUSED BY A MONOAMINE OXIDASE INHIBITOR IN A PATIENT WITH STENOSIS OF THE INTERNAL CAROTID AT ITS ORIGIN. CURE BY ENDARTERIECTOMY AND CESSATION OF THE MAOI]. GOULON M; RAPIN M; DUPAS M; COPHIGNON J; BAROIS A; LEVY-ALCOVER ; GORCE F; SIMON O Presse Med (1893); 1964 Nov; 72():2753-7. PubMed ID: 14231405 [No Abstract] [Full Text] [Related]
16. PARGYLINE, CHEESE AND ACUTE HYPERTENSION. GLAZENER FS; MORGAN WA; SIMPSON JM; JOHNSON PK JAMA; 1964 May; 188():754-5. PubMed ID: 14122686 [No Abstract] [Full Text] [Related]
18. Effect of antihypertensive (pargyline hydrochloride-methyclothiazide) therapy in three types of hypertension: preliminary report after one year of observation. Campione KM J Am Geriatr Soc; 1966 May; 14(5):490-6. PubMed ID: 9752384 [TBL] [Abstract][Full Text] [Related]
19. PARGYLINE HYDROCHLORIDE AND METHYCLOTHIAZIDE COMBINED IN THE TREATMENT OF HYPERTENSION. POLLACK PJ Curr Ther Res Clin Exp; 1965 Jan; 7():10-8. PubMed ID: 14246362 [No Abstract] [Full Text] [Related]